Board Meeting

KILITCH DRUGS (INDIA) LTD.

NSE : KILITCHBSE : 524500ISIN CODE : INE729D01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE353.253.65 (+1.04 %)
PREV CLOSE ( ) 349.60
OPEN PRICE ( ) 361.80
BID PRICE (QTY) 348.75 (21)
OFFER PRICE (QTY) 351.30 (10)
VOLUME 440
TODAY'S LOW / HIGH ( )351.80 361.80
52 WK LOW / HIGH ( )157 469.85
NSE353.006.7 (+1.93 %)
PREV CLOSE( ) 346.30
OPEN PRICE ( ) 354.05
BID PRICE (QTY) 351.05 (1)
OFFER PRICE (QTY) 352.95 (46)
VOLUME 7593
TODAY'S LOW / HIGH( ) 347.80 363.60
52 WK LOW / HIGH ( )165.3 470

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.